These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 340296

  • 1. Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide.
    Lecomte MJ, Luyckx AS, Lefebvre PJ.
    Diabete Metab; 1977 Dec; 3(4):239-43. PubMed ID: 340296
    [No Abstract] [Full Text] [Related]

  • 2. Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus.
    Aman M, Jawad F, Sultana S, Waiz-ul-Haq, Nanji R.
    J Pak Med Assoc; 1977 Mar; 27(3):293-5. PubMed ID: 409862
    [Abstract] [Full Text] [Related]

  • 3. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L, Harno K.
    Acta Endocrinol Suppl (Copenh); 1980 Mar; 239():44-52. PubMed ID: 6776763
    [Abstract] [Full Text] [Related]

  • 4. A clinical trial with glipizide - a relative new sulphonylurea.
    Singarayar J, Sunderam S.
    Med J Zambia; 1978 Mar; 12(4):97. PubMed ID: 398642
    [Abstract] [Full Text] [Related]

  • 5. [Effects of treatment with glipizide-metformin on the behavior of blood sugar, insulin and lipids after intravenous administration of glucose in diabetic subjects].
    Ferlito S, Lunetta M, Mangiagli P, Tranchida ML.
    G Clin Med; 1974 Nov; 55(11):798-818. PubMed ID: 4469884
    [No Abstract] [Full Text] [Related]

  • 6. [Glipizide: a 2d generation sulfonamide and new antidiabetic].
    Deuil R.
    Nouv Presse Med; 1975 Feb 15; 4(7):500-1. PubMed ID: 1093131
    [No Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024).
    Bandisode MS, Boshell BR.
    Horm Metab Res; 1976 Mar 15; 8(2):89-91. PubMed ID: 770300
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs.
    Lebovitz HE, Feinglos MN, Bucholtz HK, Lebovitz FL.
    J Clin Endocrinol Metab; 1977 Sep 15; 45(3):601-4. PubMed ID: 903405
    [Abstract] [Full Text] [Related]

  • 9. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F, Pempinello R, Romis L.
    Arzneimittelforschung; 1972 Nov 15; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Metabolic and hormonal response to a standardized breakfast in type 2 diabetes. Effect of glipizide].
    Scheen AJ, de la Torre D, Luyckx AS, Lefèbvre PJ.
    Rev Med Liege; 1983 Mar 15; 38(6):189-98. PubMed ID: 6344171
    [No Abstract] [Full Text] [Related]

  • 12. Influence of metformin on arginine-induced glucagon secretion in human diabetes.
    Carpentier J, Luyckx AS, Lefebvre PJ.
    Diabete Metab; 1975 Mar 15; 1():23-8. PubMed ID: 1234063
    [Abstract] [Full Text] [Related]

  • 13. [Clinical experience with Glipizide in a diabetes outpatient department].
    Jhran W.
    MMW Munch Med Wochenschr; 1977 Jul 22; 119(29-30):989-90. PubMed ID: 408638
    [No Abstract] [Full Text] [Related]

  • 14. Glipizide evaluation after a one year trial in maturity onset diabetics.
    Dowey KE, Grant AP, Hayes JR.
    Ulster Med J; 1979 Jul 22; 48(1):65-8. PubMed ID: 553357
    [No Abstract] [Full Text] [Related]

  • 15. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
    Iaroshevskiĭ IuA, Volkova EA.
    Klin Med (Mosk); 1982 Oct 22; 60(10):94-7. PubMed ID: 6757562
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE, Langlois M, Noacco C, Lorenzi M, Karam JH, Korsham PH.
    J Clin Invest; 1976 Aug 22; 58(2):320-5. PubMed ID: 783198
    [Abstract] [Full Text] [Related]

  • 17. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H, Denes A, Girard J, Collard F, Berger W.
    Horm Metab Res; 1974 Sep 22; 6(5):386-91. PubMed ID: 4417576
    [No Abstract] [Full Text] [Related]

  • 18. Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy.
    Greenfield MS, Doberne L, Rosenthal M, Vreman HJ, Reaven GM.
    Arch Intern Med; 1982 Aug 22; 142(8):1498-1500. PubMed ID: 7103631
    [Abstract] [Full Text] [Related]

  • 19. [A clinical study of a new sulfonylures hypoglycemic agent: glipizide (glibenese)(author's transl)].
    Cochet B, Balant L, Rilliet B, Zahnd G.
    Schweiz Rundsch Med Prax; 1975 May 06; 64(18):562-8. PubMed ID: 1161734
    [No Abstract] [Full Text] [Related]

  • 20. Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
    Fineberg SE, Schneider SH.
    Diabetologia; 1980 Jan 06; 18(1):49-54. PubMed ID: 6988265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.